SHARC Trademark

Trademark Overview


On Friday, August 12, 2022, a trademark application was filed for SHARC with the United States Patent and Trademark Office. The USPTO has given the SHARC trademark a serial number of 79350210. The federal status of this trademark filing is REGISTERED as of Tuesday, February 6, 2024. This trademark is owned by Celyad Oncology, Société anonyme. The SHARC trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations, namely, compositions containing immune cells for use in adoptive cellular therapy, immune cell culture, manufacture of immune cells, namely, biological preparations for the treatment of cancer; nucleic acid vectors for use in immune cells being biological preparations for the treatment of cancer

Medical care and medical analysis, namely, services for the diagnosis and treatment of cancer, in the field of and related to the manufacturing and administration of immune cells

Scientific laboratory services and research, namely, scientific laboratory services and research related to immune cells and shrna
sharc

General Information


Serial Number79350210
Word MarkSHARC
Filing DateFriday, August 12, 2022
Status700 - REGISTERED
Status DateTuesday, February 6, 2024
Registration Number7296056
Registration DateTuesday, February 6, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements


Description of MarkThe mark consists of a purple circle with a dark purple border containing a white wavy line with short white vertical lines emanating from it; to the right of the circle are five yellow circles of varying sizes. Beneath the circles is the stylized blue wording "SHARC".
Goods and ServicesPharmaceutical preparations, namely, compositions containing immune cells for use in adoptive cellular therapy, immune cell culture, manufacture of immune cells, namely, biological preparations for the treatment of cancer; nucleic acid vectors for use in immune cells being biological preparations for the treatment of cancer
Indication of Colors claimedThe color(s) dark purple, purple, white, yellow, and blue is/are claimed as a feature of the mark.
Goods and ServicesMedical care and medical analysis, namely, services for the diagnosis and treatment of cancer, in the field of and related to the manufacturing and administration of immune cells
Goods and ServicesScientific laboratory services and research, namely, scientific laboratory services and research related to immune cells and shrna

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 23, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelyad Oncology, Société anonyme
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Party NameCelyad Oncology, Société anonyme
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Party NameCelyad Oncology, Société anonyme
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Saturday, June 3, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 22, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 27, 2022APPLICATION FILING RECEIPT MAILED
Thursday, June 1, 2023ASSIGNED TO EXAMINER
Friday, June 2, 2023NON-FINAL ACTION WRITTEN
Monday, July 10, 2023REFUSAL PROCESSED BY MPU
Monday, July 10, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 1, 2023REFUSAL PROCESSED BY IB
Friday, October 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 1, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTIFICATION PROCESSED BY IB
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, May 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 10, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 10, 2024FINAL DISPOSITION PROCESSED